Background Icariin (ICA) is a bioactive compound isolated from epimedium-derived
flavonoids that modulates bone mesenchymal stem cell osteogenesis and adipogenesis …

Icariin, the main active flavonoid glucoside isolated from Herba epimedii, has been
demonstrated to be a potential alternative therapy to prevent postmenopausal osteoporosis …

Icariin, the main effective component of Herba Epimedii, has been identified to regulate the
osteogenic differentiation of rat bone marrow stromal cells (rBMSCs) and have potential …

Fat infiltration within the bone marrow is easily observed in some postmenopausal women.
Those fats are mainly derived from bone marrow mesenchymal stem cells (BMMSCs). The …

Background We previously reported that the constitutional flavonoid glycosides derived from
herb Epimedium (EF, composed of seven flavonoid compounds with common nuclear stem) …

Icariin, the major ingredient of Herba Epimedii, promotes the osteogenic differentiation of rat
bone marrow stromal cells (rBMSCs) and exerts protective effects against bone loss and …

Icariin, the main constituent of Herba Epimedii, appears to be a promising alternative to
classic drugs used to treat osteoporosis. However, the detailed molecular mechanisms of its …

Icariin, the main active flavonoid glucoside isolated from Herba epimedii (HEF), is an
anabolic agent in bone that has been reported to prevent bone loss in ovariectomized rats …

Osteoporosis is a bone disease characterized by reduced bone mass, which leads to
increased risk of bone fractures, and poses a significant risk to public health, especially in …

Objectives Icariin, a flavonoid isolated from Epimedium pubescens, has previously been
identified to exert beneficial effects on preventing bone loss and promoting bone …